3D MR Versus 3D CT for Glenohumeral Arthritis

Sponsor
NYU Langone Health (Other)
Overall Status
Completed
CT.gov ID
NCT03379545
Collaborator
(none)
31
1
1
40.8
0.8

Study Details

Study Description

Brief Summary

This study aims to assess the efficacy of three-dimensional magnetic resonance (MR) compared to three-dimensional computed tomography (CT) imaging. This proposed study is a prospective, unrandomized, single-blinded, self-controlled, and single-armed diagnostic radiological evaluation study.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: 3-dimensional (3D) magnetic resonance (MR) imaging
  • Diagnostic Test: 3D computed tomography (CT) imaging
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
31 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Preoperative Magnetic Resonance as an Alternative to Computed Tomography Three-Dimensional Imaging for Characterizing Bone Loss in Shoulder Arthroplasty Candidates With Glenohumeral Osteoarthritis: A Prospective, Blinded, and Controlled Clinical Trial.
Actual Study Start Date :
Jan 11, 2017
Actual Primary Completion Date :
Dec 21, 2018
Actual Study Completion Date :
Jun 5, 2020

Arms and Interventions

Arm Intervention/Treatment
Other: 3D MR and 3D CT Imaging

All shoulder arthroplasty candidates with glenohumeral osteoarthritis will be receiving both 3D computed tomography (CT) and 3D non-contrast magnetic resonance (MR) imaging.

Diagnostic Test: 3-dimensional (3D) magnetic resonance (MR) imaging
MRI is performed using 3T scanners with a dedicated 16-channel shoulder array coils. The MRI sequences include 3-mm slice thickness and 0.5-mm gap width with a field of view of 14 or 15 cm. There were 6 diagnostic sequences with axial, coronal, and sagittal proton density weighting as well as coronal T2 with frequency selective fat suppression and sagittal T1 images.

Diagnostic Test: 3D computed tomography (CT) imaging
The CT protocol consists of 3-mm axial images of the glenoid reconstructed into 1-mm sagittal and coronal 2D reconstructions using the following parameters: 120 kV, 280 mA, and pitch of 0.9. The CT data were also used to produce a 3D reconstruction of each glenoid.

Outcome Measures

Primary Outcome Measures

  1. Glenoid Version [3 Months]

    All scans from 3D CT and 3D MR imaging were reviewed carefully for the presence of any morphological changes. For the determination of glenoid version, a line was drawn between the anterior and posterior margins of the glenoid. The transverse axis of the scapula was determined by a line drawn from the midpoint of the genoid fossa to the medial end of the image of the scapula; a line drawn perpendicular to this was defined as a line of neutral version. The angle between the line of neutral version and the line connecting the anterior and posterior margins of the glenoid was measured and recorded as the Glenoid Version.

  2. Glenoid Inclination [3 Months]

    The 3D MRI glenoid inclination is measured by the two observers with the same method used for CT 3D glenoid inclination measurement following generating a new 2D axial MR images form the 3D MRI model using the three-point method. A line on the supraspinatus fossa and 3 points are drawn: Point S represents the inferior border of the glenoid, point R represents the intersection of the supraspinatus fossa line with the glenoid surface, and point A represents the vertex of the right triangle created by the line of the supraspinatus fossa and a perpendicular line passing through point S; this line (RS) is the hypotenuse of the right triangle. The inclination corresponds to the area in which the glenoid component of RSA is implanted.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients suffering from glenohumeral OA;

  • Radiographic evidence of severe glenoid erosion;

  • Indication for TSA based on clinical exam;

  • Patient is willing to participate by complying with pre-operative visit requirements;

  • Patient is willing and able to review and sign a study informed consent form.

Exclusion Criteria:
  • Prior arthroplasty at the affected shoulder;

  • Patients with inflammatory arthritis;

  • Patients with post-capsulorrhaphy arthritis;

  • Patients with post-traumatic arthritis;

  • Patients with rotator cuff tear arthropathy;

  • Patients exhibiting a lack of physical or mental ability to perform or comply with the study procedures;

  • Patients who are pregnant;

  • Patients with implanted medical devices that are contraindicated to exposure up to a 3.0-tesla magnetic field.

Contacts and Locations

Locations

Site City State Country Postal Code
1 New York University School of Medicine New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health

Investigators

  • Principal Investigator: Joseph D Zuckerman, MD, NYU Langone Health

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT03379545
Other Study ID Numbers:
  • 17-00500
First Posted:
Dec 20, 2017
Last Update Posted:
Mar 25, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Shoulder Arthroplasty (SA)
Arm/Group Description 3D computed tomography (CT) and 3D non-contrast magnetic resonance (MR) 3-dimensional (3D) magnetic resonance (MR): MRI is performed using 3T scanners with a dedicated 16-channel shoulder array coils. The MRI sequences include 3-mm slice thickness and 0.5-mm gap width with a field of view of 14 or 15 cm. There were 6 diagnostic sequences with axial, coronal, and sagittal proton density weighting as well as coronal T2 with frequency selective fat suppression and sagittal T1 images. 3D computed tomography (CT) imaging: The CT protocol consists of 3-mm axial images of the glenoid reconstructed into 1-mm sagittal and coronal 2D reconstructions using the following parameters: 120 kV, 280 mA, and pitch of 0.9. The CT data were also used to produce a 3D reconstruction of each glenoid.
Period Title: Overall Study
STARTED 29
COMPLETED 29
NOT COMPLETED 0

Baseline Characteristics

Arm/Group Title Shoulder Arthroplasty (SA)
Arm/Group Description 3D computed tomography (CT) and 3D non-contrast magnetic resonance (MR) 3-dimensional (3D) magnetic resonance (MR): MRI is performed using 3T scanners with a dedicated 16-channel shoulder array coils. The MRI sequences include 3-mm slice thickness and 0.5-mm gap width with a field of view of 14 or 15 cm. There were 6 diagnostic sequences with axial, coronal, and sagittal proton density weighting as well as coronal T2 with frequency selective fat suppression and sagittal T1 images. 3D computed tomography (CT) imaging: The CT protocol consists of 3-mm axial images of the glenoid reconstructed into 1-mm sagittal and coronal 2D reconstructions using the following parameters: 120 kV, 280 mA, and pitch of 0.9. The CT data were also used to produce a 3D reconstruction of each glenoid.
Overall Participants 29
Age (years) [Median (Full Range) ]
Median (Full Range) [years]
68
Sex: Female, Male (Count of Participants)
Female
10
34.5%
Male
19
65.5%
Race and Ethnicity Not Collected (Count of Participants)
Region of Enrollment (participants) [Number]
United States
29
100%

Outcome Measures

1. Primary Outcome
Title Glenoid Version
Description All scans from 3D CT and 3D MR imaging were reviewed carefully for the presence of any morphological changes. For the determination of glenoid version, a line was drawn between the anterior and posterior margins of the glenoid. The transverse axis of the scapula was determined by a line drawn from the midpoint of the genoid fossa to the medial end of the image of the scapula; a line drawn perpendicular to this was defined as a line of neutral version. The angle between the line of neutral version and the line connecting the anterior and posterior margins of the glenoid was measured and recorded as the Glenoid Version.
Time Frame 3 Months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Shoulder Arthroplasty (SA)
Arm/Group Description 3D computed tomography (CT) and 3D non-contrast magnetic resonance (MR) 3-dimensional (3D) magnetic resonance (MR): MRI is performed using 3T scanners with a dedicated 16-channel shoulder array coils. The MRI sequences include 3-mm slice thickness and 0.5-mm gap width with a field of view of 14 or 15 cm. There were 6 diagnostic sequences with axial, coronal, and sagittal proton density weighting as well as coronal T2 with frequency selective fat suppression and sagittal T1 images. 3D computed tomography (CT) imaging: The CT protocol consists of 3-mm axial images of the glenoid reconstructed into 1-mm sagittal and coronal 2D reconstructions using the following parameters: 120 kV, 280 mA, and pitch of 0.9. The CT data were also used to produce a 3D reconstruction of each glenoid.
Measure Participants 29
3D-MR Scan
12.1
(8.7)
3D-CT Scan
11.4
(7.4)
2. Primary Outcome
Title Glenoid Inclination
Description The 3D MRI glenoid inclination is measured by the two observers with the same method used for CT 3D glenoid inclination measurement following generating a new 2D axial MR images form the 3D MRI model using the three-point method. A line on the supraspinatus fossa and 3 points are drawn: Point S represents the inferior border of the glenoid, point R represents the intersection of the supraspinatus fossa line with the glenoid surface, and point A represents the vertex of the right triangle created by the line of the supraspinatus fossa and a perpendicular line passing through point S; this line (RS) is the hypotenuse of the right triangle. The inclination corresponds to the area in which the glenoid component of RSA is implanted.
Time Frame 3 Months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title 3D MR and 3D CT Imaging
Arm/Group Description All shoulder arthroplasty candidates with glenohumeral osteoarthritis will be receiving both 3D computed tomography (CT) and 3D non-contrast magnetic resonance (MR) imaging. 3-dimensional (3D) magnetic resonance (MR) imaging: MRI is performed using 3T scanners with a dedicated 16-channel shoulder array coils. The MRI sequences include 3-mm slice thickness and 0.5-mm gap width with a field of view of 14 or 15 cm. There were 6 diagnostic sequences with axial, coronal, and sagittal proton density weighting as well as coronal T2 with frequency selective fat suppression and sagittal T1 images. 3D computed tomography (CT) imaging: The CT protocol consists of 3-mm axial images of the glenoid reconstructed into 1-mm sagittal and coronal 2D reconstructions using the following parameters: 120 kV, 280 mA, and pitch of 0.9. The CT data were also used to produce a 3D reconstruction of each glenoid.
Measure Participants 29
3D-MR Scan
89.2
(7.2)
3D-CT Scan
91
(8.1)

Adverse Events

Time Frame 6 months
Adverse Event Reporting Description
Arm/Group Title Shoulder Arthroplasty (SA)
Arm/Group Description 3D computed tomography (CT) and 3D non-contrast magnetic resonance (MR) 3-dimensional (3D) magnetic resonance (MR): MRI is performed using 3T scanners with a dedicated 16-channel shoulder array coils. The MRI sequences include 3-mm slice thickness and 0.5-mm gap width with a field of view of 14 or 15 cm. There were 6 diagnostic sequences with axial, coronal, and sagittal proton density weighting as well as coronal T2 with frequency selective fat suppression and sagittal T1 images. 3D computed tomography (CT) imaging: The CT protocol consists of 3-mm axial images of the glenoid reconstructed into 1-mm sagittal and coronal 2D reconstructions using the following parameters: 120 kV, 280 mA, and pitch of 0.9. The CT data were also used to produce a 3D reconstruction of each glenoid.
All Cause Mortality
Shoulder Arthroplasty (SA)
Affected / at Risk (%) # Events
Total 0/29 (0%)
Serious Adverse Events
Shoulder Arthroplasty (SA)
Affected / at Risk (%) # Events
Total 0/29 (0%)
Other (Not Including Serious) Adverse Events
Shoulder Arthroplasty (SA)
Affected / at Risk (%) # Events
Total 0/29 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Joseph Zuckerman, MD
Organization NYU Langone Health
Phone 212-598-6674
Email Joseph.Zuckerman@nyulangone.org
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT03379545
Other Study ID Numbers:
  • 17-00500
First Posted:
Dec 20, 2017
Last Update Posted:
Mar 25, 2021
Last Verified:
Mar 1, 2021